American International Group, Inc. Solid Biosciences Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.43 - $1.24 $12,729 - $36,708	-29,604 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.74 - $1.79 $1,541 - $3,728	-2,083 Reduced 6.57%	29,604 $36,000
Q4 2021 Feb 11, 2022	SELL	$1.69 - $2.46 $1,602 - $2,332	-948 Reduced 2.9%	31,687 $55,000
Q3 2021 Nov 12, 2021	SELL	$2.38 - $3.77 $1,846 - $2,925	-776 Reduced 2.32%	32,635 $78,000
Q2 2021 Aug 13, 2021	BUY	$3.49 - $5.51 $59,413 - $93,802	17,024 Added 103.89%	33,411 $122,000
Q1 2021 May 07, 2021	BUY	$5.37 - $10.72 $236 - $471	44 Added 0.27%	16,387 $91,000
Q4 2020 Feb 12, 2021	BUY	$3.08 - $7.79 $4,814 - $12,175	1,563 Added 10.58%	16,343 $124,000
Q3 2020 Nov 04, 2020	SELL	$2.02 - $3.08 $678 - $1,034	-336 Reduced 2.22%	14,780 $30,000
Q2 2020 Aug 12, 2020	BUY	$2.1 - $3.42 $7,312 - $11,908	3,482 Added 29.93%	15,116 $44,000
Q1 2020 May 04, 2020	SELL	$2.31 - $4.43 $1,554 - $2,981	-673 Reduced 5.47%	11,634 $28,000
Q4 2019 Feb 05, 2020	SELL	$2.82 - $12.9 $290 - $1,328	-103 Reduced 0.83%	12,307 $55,000
Q3 2019 Nov 08, 2019	BUY	$4.33 - $11.64 $12,076 - $32,463	2,789 Added 28.99%	12,410 $128,000
Q2 2019 Aug 13, 2019	BUY	$4.6 - $10.13 $8,505 - $18,730	1,849 Added 23.79%	9,621 $55,000
Q1 2019 May 06, 2019	SELL	$7.19 - $32.37 $1,811 - $8,157	-252 Reduced 3.14%	7,772 $72,000
Q4 2018 Feb 13, 2019	SELL	$21.32 - $46.34 $1,300 - $2,826	-61 Reduced 0.75%	8,024 $215,000
Q3 2018 Nov 09, 2018	BUY	$36.35 - $51.7 $78,297 - $111,361	2,154 Added 36.32%	8,085 $381,000
Q2 2018 Aug 08, 2018	BUY	$7.33 - $43.15 $938 - $5,523	128 Added 2.21%	5,931 $211,000
Q1 2018 May 07, 2018	BUY	$7.19 - $33.17 $41,723 - $192,485	5,803 New	5,803 $44,000

Others Institutions Holding SLDB

# of Institutions

Shares Held

Call Options Held

Put Options Held

View Full List

About Solid Biosciences Inc.

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $31M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

More about SLDB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account